RICHARD W WHITE
Architects in Cambridge, MA
License number
Massachusetts 2105
Expiration Date
Aug 31, 2003
Type
Architect
Address
Address
Cambridge, MA 02138
Personal information
See more information about RICHARD W WHITE at radaris.comName
Address
Phone
511 Trafton Rd, Springfield, MA 01108
51 Maple St UNIT 133, Rockland, MA 02370
524 Hadley West Dr, Haverhill, MA 01832
51 Fairview Ave, W Springfield, MA 01089
Professional information
Managing Director At Oppenheimer &Amp; Co.
Position:
Member of Board of Energy and Environmental Systems at National Academies, Board Member at Draper Laboratory, Chairman and Board Member at Mercury Solar Systems, Managing Director at Oppenheimer & Co., Board Member at Escalade Inc., Board Member at G-III Apparel Group
Location:
Greater New York City Area
Industry:
Financial Services
Work:
National Academies
- Washington D.C. Metro Area since Jan 2009
-
Member of Board of Energy and Environmental Systems
Draper Laboratory
- Cambridge, MA since Oct 2008
-
Board Member
Mercury Solar Systems
- Portchester, NY since Aug 2008
-
Chairman and Board Member
Oppenheimer & Co.
- New York, NY since Jun 2004
-
Managing Director
Escalade Inc.
- Evansville, Indiana since Jan 2004
-
Board Member
G-III Apparel Group
- New York, NY since Jan 2003
-
Board Member
Lakes Entertainment
- Greater Minneapolis-St. Paul Area Jan 2006 - Jun 2013
-
Board Member
ActivIdentity
- Fremont, CA 2003 - 2008
-
Board Member
Midway Games
1996 - 2003
-
Board Member
CIBC Capital Partners
- New York, NY Nov 1997 - Feb 2002
-
Managing Director
Vestcom
- West Caldwell, NJ 1996 - 2002
-
Board Member
Oppenheimer & Co., Inc.
- New York, NY Nov 1985 - Oct 1997
-
Managing Director
Education:
University of Pennsylvania - The Wharton School 1976 - 1978
MBA Tufts University 1972 - 1976
BA Economics
MBA Tufts University 1972 - 1976
BA Economics
Methods For Treatment Of Melanoma
US Patent:
2014003, Jan 30, 2014
Filed:
Feb 8, 2012
Appl. No.:
13/983090
Inventors:
Leonard Zon - Wellesley MA, US
Richard M. White - Cambridge MA, US
Richard M. White - Cambridge MA, US
Assignee:
DANA-FARBER CANCER INSTITUTE, INC. - Boston MA
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:
A61K 31/437, A61K 31/277, A61K 31/42
US Classification:
514300, 435 32, 435 612
Abstract:
The present invention is directed to methods for treatment of melanoma using an inhibitor of dihydroorotate dehydrogenase (DHODH) and to combination therapies that involve administering to a subject an inhibitor of oncogenic BRAF (e.g. BRAF(V600E)), as well as an inhibitor of dihydroorotate dehydrogenase (DHODH). Assays for identifying compounds useful for the treatment of melanoma are also provided. The methods herein are directed to screening for compounds or agents that inhibit neural crest progenitor formation in a zebra fish model of melanoma.